20% OFF shipping at judo-club-schaffhausen.ch on orders over $79 + up to 10% OFF products
judo-club-schaffhausen.ch
home > protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease > protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
download picture
Crystal Structures of the Plant Phospholipase A1 Proteins Reveal a Unique Dimerization Domain Lys C KPL ApS Discovery of CREBH C: A Novel Hepatokine Regulating Lipoprotein Lipase Activity and Metabolic Disorders Medicine Innovates Identification of a Gain of Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia Circulation Lipase Powder The Cheesemaker
Shopping security

Shopping security

Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and  Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody  MEDI5884 in Patients With Stable Coronary Artery Disease
protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and  Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody  MEDI5884 in Patients With Stable Coronary Artery Disease
protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and  Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody  MEDI5884 in Patients With Stable Coronary Artery Disease
protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and  Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody  MEDI5884 in Patients With Stable Coronary Artery Disease
protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and  Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody  MEDI5884 in Patients With Stable Coronary Artery Disease

protein lipase c LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease

Item no : 20007856726
sold recently : Login >>
US$ 20.96
Pay in 4 interest-free payments of $5.24 Learn more
Min. order: 1piece

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jun 20 - Jun 25

Enjoy 20% off shipping

US$ 20.96

1-11

US$ 18.86

12-35

US$ 14.67

36-59

US$ 12.58

60+

US$40

Get now

Sign up to your membership to get coupons up to

15%

Get now

Opportunity to enjoy order discount up to 15% off

Please add the products
Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

Discover Niche Categories That Outsell protein lipase c

Top-Converting Item to Boost Your Average Order

recommand products

GMUC
GMUC

US$ 22.13

Min. order: 1 piece

4.0 (144 reviews)

Sold : Login>>